Earningsreport

Q1/2024 3/31/2024 EPS -0.250 ZacksConsensus -0.270 ActVsEst 0.020 - Beat

CorMedix Inc.  (CRMD) 
NASDAQ:AMEX Investor Relations: cormedix.com